Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1984 Aug;18(2):240–243. doi: 10.1111/j.1365-2125.1984.tb02461.x

Gender and oral contraceptive steroids as determinants of drug glucuronidation: effects on clofibric acid elimination.

J O Miners, R A Robson, D J Birkett
PMCID: PMC1463532  PMID: 6487463

Abstract

The disposition of clofibric acid, a drug metabolised largely by glucuronidation, was studied in eight males, eight females and eight females receiving oral contraceptive steroids (OCS). Clofibric acid plasma clearance was not significantly different in males compared to the control female group but was 48% greater (P less than 0.01) in women receiving OCS compared to non-pill using females. This difference was due to an alteration in clofibric acid metabolic clearance as there were no differences between the groups in clofibric acid free fraction. Along with previous data the results suggest that induction of drug glucuronidation by OCS may be of clinical importance, although any sex-related differences are unlikely to be of clinical significance.

Full text

PDF
243

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abernethy D. R., Divoll M., Ochs H. R., Ameer B., Greenblatt D. J. Increased metabolic clearance of acetaminophen with oral contraceptive use. Obstet Gynecol. 1982 Sep;60(3):338–341. [PubMed] [Google Scholar]
  2. Abernethy D. R., Greenblatt D. J., Ochs H. R., Weyers D., Divoll M., Harmatz J. S., Shader R. I. Lorazepam and oxazepam kinetics in women on low-dose oral contraceptives. Clin Pharmacol Ther. 1983 May;33(5):628–632. doi: 10.1038/clpt.1983.85. [DOI] [PubMed] [Google Scholar]
  3. Benet L. Z., Galeazzi R. L. Noncompartmental determination of the steady-state volume of distribution. J Pharm Sci. 1979 Aug;68(8):1071–1074. doi: 10.1002/jps.2600680845. [DOI] [PubMed] [Google Scholar]
  4. Bock K. W., Burchell B., Dutton G. J., Hänninen O., Mulder G. J., Owens I. S., Siest G., Tephly T. R. UDP-glucuronosyltransferase activities. Guidelines for consistent interim terminology and assay conditions. Biochem Pharmacol. 1983 Mar 15;32(6):953–955. doi: 10.1016/0006-2952(83)90610-x. [DOI] [PubMed] [Google Scholar]
  5. Caldwell J., Emudianughe T. S., Smith R. L. Species variation in the taurine conjugation of clofibric acid [proceedings]. Br J Pharmacol. 1979 Jul;66(3):421P–422P. [PMC free article] [PubMed] [Google Scholar]
  6. Divoll M., Abernethy D. R., Ameer B., Greenblatt D. J. Acetaminophen kinetics in the elderly. Clin Pharmacol Ther. 1982 Feb;31(2):151–156. doi: 10.1038/clpt.1982.24. [DOI] [PubMed] [Google Scholar]
  7. Miners J. O., Attwood J., Birkett D. J. Influence of sex and oral contraceptive steroids on paracetamol metabolism. Br J Clin Pharmacol. 1983 Nov;16(5):503–509. doi: 10.1111/j.1365-2125.1983.tb02207.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Mitchell M. C., Hanew T., Meredith C. G., Schenker S. Effects of oral contraceptive steroids on acetaminophen metabolism and elimination. Clin Pharmacol Ther. 1983 Jul;34(1):48–53. doi: 10.1038/clpt.1983.127. [DOI] [PubMed] [Google Scholar]
  9. Mucklow J. C., Fraser H. S., Bulpitt C. J., Kahn C., Mould G., Dollery C. T. Environmental factors affecting paracetamol metabolism in London factory and office workers. Br J Clin Pharmacol. 1980 Jul;10(1):67–74. doi: 10.1111/j.1365-2125.1980.tb00503.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Männistö P. T., Tuomisto J., Jounela A., Penttilä O. Pharmacokinetics of clofibrate and chlorophenoxy isobutyric aicd. I. Cross-over studies on human volunteers. Acta Pharmacol Toxicol (Copenh) 1975 Apr;36(4):353–365. doi: 10.1111/j.1600-0773.1975.tb00802.x. [DOI] [PubMed] [Google Scholar]
  11. Sedaghat A., Ahrens E. H., Jr Lack of effect of cholestyramine on the pharmacokinetics of clofibrate in man. Eur J Clin Invest. 1975 Apr;5(2):177–185. doi: 10.1111/j.1365-2362.1975.tb00444.x. [DOI] [PubMed] [Google Scholar]
  12. Veenendaal J. R., Brooks P. M., Meffin P. J. Probenecid-clofibrate interaction. Clin Pharmacol Ther. 1981 Mar;29(3):351–358. doi: 10.1038/clpt.1981.48. [DOI] [PubMed] [Google Scholar]
  13. Veenendaal J. R., Meffin P. J. The simultaneous analysis of clofibric acid and probenecid and the direct analysis of clofibric acid glucuronide by high-performance liquid chromatography. J Chromatogr. 1981 Apr 10;223(1):147–154. doi: 10.1016/s0378-4347(00)80077-8. [DOI] [PubMed] [Google Scholar]
  14. Wójcicki J., Gawrońska-Szklarz B., Kazimierczyk J., Baskiewicz Z., Raczyński A. Comparative pharmacokinetics of paracetamol in men and women considering follicular and luteal phases. Arzneimittelforschung. 1979;29(2):350–352. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES